GeoVax Labs (GOVX) vs Revelation Biosciences (REVB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Revelation Biosciences is the larger company by market cap ($3.2 million vs $2.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GOVX | REVB |
|---|---|---|
| Share price | $0.29 | $0.81 |
| Market cap | $2.93M | $3.23M |
| 1-day change | +1.19% | +3.85% |
| P/E ratio (TTM) | — | 0.18 |
| EPS (TTM) | $-8.84 | $4.60 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.75 | $5.96 |
| 52-week low | $0.2705 | $0.75 |
| Distance from 52-week high | -98.16% | -86.41% |
| Analyst consensus | none | none |
| Avg. price target upside | +3348.28% | +2091.36% |
| Average volume | 771.47K | 39.50K |
| Shares outstanding | 10.10M | 3.98M |
| Employees | 19 | 8 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About GeoVax Labs
GOVX stock →GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine.
Health Care · Biotechnology: Pharmaceutical Preparations · 19 employees
About Revelation Biosciences
REVB stock →Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health.
Health Care · Biotechnology: Pharmaceutical Preparations · 8 employees
GOVX vs REVB FAQ
Which is bigger, GeoVax Labs or Revelation Biosciences?
Revelation Biosciences (REVB) is larger, with a market capitalization of $3.23M compared with $2.93M for GeoVax Labs (GOVX).
Are GeoVax Labs and Revelation Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.